Office:
103 Carnegie Center, Suite 103
 
Princeton, NJ 08540,USA
Phone:
(609) 799-0050
Fax:
(609) 497-9695

 


 

 

 

Jurij Petrin, M.D.
President and Founder of the company

After an academic career in Internal medicine at the University of Ljubljana Medical School he joined Bristol-Myers Squibb in Munich, Germany as the Medical Director for Central and Eastern Europe. He organized and conducted first GCP based clinical trials in the region for BMS.

He then moved to Princeton to become Executive Director of International Regulatory Affairs where he supervised international filings and approvals of new and supplemental submissions of a number of BMS compounds, among others: paclitaxel (Taxol), stavudine (Zerit), cefprozil (Cefzil), cefepime (Maxipime), didanosine (Videx), pravastatin (Pravachol), irbesartan (Aprovel), butorphanol (Stadol), nefazodone (Serzone), fosinopril (Monopril), gatifloxacin (Tequin), etc.

In the last several years he was Vice President Intercontinental Regulatory Science at Bristol-Myers Squibb, responsible for regulatory activities in the markets outside of the US and Europe.

Dr. Petrin is author or co-author of over 40 papers or chapters in books. He is a member of numerous international professional associations, among them American College of Physicians/American Society of Internal Medicine (ACP-ASIM), High Blood Pressure Scientific Council of the American Heart Association, International Society of Hypertension (ISH), American Society of Hypertension (ASH), Drug Information Association (DIA), Slovenian Society of Physicians, etc.

In 2002, the Drug Control Division of the Food and Drug Administration of Thailand has nominated Dr. Petrin and his company as the consultant company to the Thai FDA on Pharmaceutical Harmonization.

He participates regularly at various international pharmaceutical meetings, organized by DIA, IBC, CMR Int., IIR, Eudipharm, and others, either as the presenter or session chair. He teaches a course in Global Regulatory Affairs at the Graduate Program in RA/QA at the Temple University School of Pharmacy.


   

All rights reserved.